|
Press Releases |
|
|
|
Friday, November 25, 2022 |
|
Jacobson Pharma Announces FY2023 Interim Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products, today announced the interim results of the Company and its subsidiaries (collectively the "Group") for the six months ended 30 September 2022 (the "Reporting Period"). more info >> |
|
Wednesday, June 29, 2022 |
|
Jacobson Pharma Announces FY2022 Annual Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products, today announced the annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2022 ("FY2022" or the "Reporting Period"). more info >> |
|
Wednesday, June 15, 2022 |
|
Ban Loong, Jacobson & JBM Form Joint Venture to Tap Specialty Drugs and Branded Healthcare Markets in Greater China and Asia |
Ban Loong Holdings Limited ("Ban Loong", together with its subsidiaries, "Ban Loong Group"; stock code: 0030.HK), of which Yunnan Baiyao Group Co., Ltd. (stock code: 000538.SHE) is the controlling shareholder, Jacobson Pharma Corporation Limited ("Jacobson", together with its subsidiaries (excluding JBM Group) more info >> |
|
Monday, March 14, 2022 |
|
Jacobson Pharma's Chairman Uplifts Shareholding to Above 60% |
Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma Corporation Limited (the "Company"; together with its subsidiaries, the "Group"; Stock Code: 2633), a leading company engaged in the research more info >> |
|
Friday, November 26, 2021 |
|
Jacobson Pharma Announces FY2022 Interim Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of essential medicines more info >> |
|
Tuesday, June 29, 2021 |
|
Jacobson Pharma Announces FY2021 Annual Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products more info >> |
|
Friday, February 5, 2021 |
|
JBM (Healthcare) Limited Debuts on The Main Board of SEHK |
JBM (Healthcare) Limited ("JBM Healthcare" or "Company", together with its subsidiaries, the "Group"), a Hong Kong-based company that markets and distributes branded healthcare products across Greater China, Southeast Asia and certain other countries, started trading today on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK") under stock code 2161. more info >> |
|
Monday, January 25, 2021 |
|
JBM (Healthcare) Limited to Be Spun Off from Jacobson Pharma Corporation Limited |
JBM (Healthcare) Limited ("JBM Healthcare" or "Company" and, together with its subsidiaries, the "Group"), a Hong Kong-based company that markets and distributes branded healthcare products with product footprint across Greater China, Southeast Asia and certain other countries, today announced details of the proposed listing of its shares on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK"). more info >> |
|
Friday, January 15, 2021 |
|
Jacobson Pharma's Proposed Spin-off and Separate Listing of JBM (Healthcare) Limited on The Main Board of The Stock Exchange of Hong Kong Limited |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines more info >> |
|
Friday, November 27, 2020 |
|
Jacobson Pharma Announces FY2021 Interim Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced the interim results of the Company and its subsidiaries (collectively the "Group") for the six months ended 30 September 2020 (the "reporting period"). more info >> |
|
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Mitsubishi Heavy Industries and NGK to Jointly Develop Hydrogen Purification System from Ammonia Cracking Gas
Apr 18, 2024 17:01 JST
|
|
|
Crown Digital Spearheads the Future of AI in F&B with Ella the Robobarista at AIM Global
Apr 18, 2024 16:00 HKT/SGT
|
|
|
The Executive Centre Announces Record Revenue in FY2023 Annual Results
Apr 18, 2024 16:00 HKT/SGT
|
|
|
Microex Launches Web3.0 Financial Trading Solution - Pioneering Innovation in Financial Technology
Apr 18, 2024 14:00 HKT/SGT
|
|
|
Toyota Launches All-New Land Cruiser "250" Series in Japan
Apr 18, 2024 13:39 JST
|
|
|
Fujitsu and Oracle collaborate to deliver sovereign cloud and AI capabilities in Japan
Apr 18, 2024 11:14 JST
|
|
|
Eisai: Research on Treatments for Alzheimer's Disease Based on Its Pathological Mechanisms Recieves Award for Science and Technology (Research Category)
Apr 18, 2024 10:53 JST
|
|
|
All-New Triton Confirmed as First Double-Cab Pickup Truck to Achieve 2024 Five-Star ANCAP Safety Rating
Apr 18, 2024 9:22 JST
|
|
|
The Rapidly Evolving Real Estate Landscape: Redefine Real Estate Summit Connects Key Players in South East Asia
Apr 18, 2024 08:11 HKT/SGT
|
|
|
Prestigious titles for top developers at the 14th PropertyGuru Asia Property Awards (Singapore)
Apr 18, 2024 08:00 HKT/SGT
|
|
|
Eesee Implements Blockpass for Compliance in Digital Assets Marketplace
Apr 18, 2024 07:00 HKT/SGT
|
|
|
A new spin on materials analysis
Apr 17, 2024 22:00 HKT/SGT
|
|
|
Hong Kong Interior Design Firm Junee (JUNE) to Debut on the Nasdaq
Apr 17, 2024 21:30 HKT/SGT
|
|
|
To acquire stake in Hangzhou Bizike, Phoenitron Holdings has eye on trillion-dollar e-commerce market
Apr 17, 2024 20:06 HKT/SGT
|
|
|
Eisai's Antiepileptic Drug Fycompa Injection Formulation Launched In Japan
Apr 17, 2024 16:17 JST
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|